Delayed initiation of radiotherapy for glioblastoma: how important is it to push to the front (or the back) of the line?
- 24 April 2011
- journal article
- review article
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 105 (1) , 1-7
Abstract
Glioblastoma is a malignant tumor characterized by a rapid proliferation rate. Contemporary multi-modality treatment consists of maximal surgical resection followed by radiation therapy (RT) combined with cytotoxic chemotherapy. The optimal timing of these different steps is not known. Four studies from the pre-temozolomide era, encompassing a total of 4,584 subjects, have examined the consequences of a delay between resection and starting RT. Whereas the two small single-institution studies found this delay to be detrimental, two large multi-institutional studies found delay to be either slightly beneficial or at least not harmful. Here, we critically compare the methodologies and results presented in these studies, and include a novel analysis of the combined datasets. We conclude that moderate wait periods (up to 4–6 weeks post-operatively) are safe and may be modestly beneficial. Conversely, there is no evidence to justify waiting longer than 6 weeks. Underlying radiobiological principles are discussed.Keywords
This publication has 50 references indexed in Scilit:
- Cancer stem cells at the crossroads of current cancer therapy failures—Radiation oncology perspectiveSeminars in Cancer Biology, 2010
- Prognostic Significance of Growth Kinetics in Newly Diagnosed Glioblastomas Revealed by Combining Serial Imaging with a Novel Biomathematical ModelCancer Research, 2009
- The timing of cranial radiation in elderly patients with newly diagnosed glioblastoma multiformeNeuro-Oncology, 2009
- Short Delay in Initiation of Radiotherapy May Not Affect Outcome of Patients With Glioblastoma: A Secondary Analysis From the Radiation Therapy Oncology Group DatabaseJournal of Clinical Oncology, 2009
- The relationship between waiting time for radiotherapy and clinical outcomes: A systematic review of the literatureRadiotherapy and Oncology, 2008
- The role of hypoxia-inducible factors in tumorigenesisCell Death & Differentiation, 2008
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaNew England Journal of Medicine, 2005
- Tumor Volume and Local Control in Primary Radiotherapy of Nasopharyngeal CarcinomaActa Oncologica, 1999
- Does surgery disseminate or accelerate cancer?The Lancet, 1995
- Growth rate and radiosensitivity of human tumours—II: Radiosensitivity of human tumoursEuropean Journal of Cancer (1965), 1966